Cargando…
A Three-Case Series of Thrombotic Deaths in Patients over 50 with Comorbidities Temporally after modRNA COVID-19 Vaccination
Coronavirus disease 2019 (COVID-19) is the most dramatic pandemic of the new millennium; to counteract it, specific vaccines have been launched in record time under emergency use authorization or conditional marketing authorization by virtue of a favorable risk/benefit balance. Among the various tec...
Autores principales: | Roncati, Luca, Manenti, Antonio, Corsi, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032304/ https://www.ncbi.nlm.nih.gov/pubmed/35456110 http://dx.doi.org/10.3390/pathogens11040435 |
Ejemplares similares
-
aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model
por: Chen, Jinmiao, et al.
Publicado: (2019) -
Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells
por: Haideri, Tahir, et al.
Publicado: (2022) -
BMP-2 and VEGF-A modRNAs in collagen scaffold synergistically drive bone repair through osteogenic and angiogenic pathways
por: Geng, Yingnan, et al.
Publicado: (2021) -
Engineered exosomes enriched in netrin-1 modRNA promote axonal growth in spinal cord injury by attenuating inflammation and pyroptosis
por: Lu, Xiao, et al.
Publicado: (2023) -
Quantitative Systems Pharmacology Model of hUGT1A1‐modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler‐Najjar Syndrome Type 1
por: Apgar, Joshua F., et al.
Publicado: (2018)